Group One Trading’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$127K Sell
12,070
-26,740
-69% -$261K ﹤0.01% 4512
2025
Q4
$446K Sell
38,810
-7,670
-17% -$118K ﹤0.01% 3642
2025
Q3
$1.13M Buy
46,480
+41,630
+858% +$693K ﹤0.01% 2900
2025
Q2
$79.8K Buy
4,850
+210
+5% +$3.63K ﹤0.01% 5175
2025
Q1
$84.4K Sell
4,640
-10,020
-68% -$286K ﹤0.01% 4727
2024
Q4
$544K Buy
14,660
+1,730
+13% +$66.2K ﹤0.01% 3098
2024
Q3
$414K Buy
12,930
+2,980
+30% +$165K ﹤0.01% 3005
2024
Q2
$817K Sell
9,950
-12,230
-55% -$1.32M ﹤0.01% 2160
2024
Q1
$3.21M Buy
22,180
+14,980
+208% +$1.26M 0.01% 1140
2023
Q4
$663K Buy
7,200
+2,610
+57% +$265K ﹤0.01% 2832
2023
Q3
$757K Buy
4,590
+3,340
+267% +$434K ﹤0.01% 2536
2023
Q2
$79K Buy
1,250
+920
+279% +$55.7K ﹤0.01% 4855
2023
Q1
$11.2K Buy
330
+80
+32% +$4.18K ﹤0.01% 5871
2022
Q4
$14.4K Buy
250
+50
+25% +$3.09K ﹤0.01% 5821
2022
Q3
$19K Sell
200
-10
-5% -$1.42K ﹤0.01% 6094
2022
Q2
$47K Sell
210
-40
-16% -$13.4K ﹤0.01% 5609
2022
Q1
$137K Buy
250
+200
+400% +$121K ﹤0.01% 5182
2021
Q4
$33K Sell
50
-500
-91% -$382K ﹤0.01% 6634
2021
Q3
$462K Sell
550
-150
-21% -$152K ﹤0.01% 4285
2021
Q2
$889K Buy
700
+170
+32% +$192K ﹤0.01% 3557
2021
Q1
$581K Hold
530
﹤0.01% 3847
2020
Q4
$757K Buy
530
+90
+20% +$96K ﹤0.01% 2899
2020
Q3
$311K Sell
440
-30
-6% -$21.8K ﹤0.01% 3289
2020
Q2
$329K Sell
470
-610
-56% -$352K ﹤0.01% 2960
2020
Q1
$378K Buy
1,080
+910
+535% +$645K ﹤0.01% 2249
2019
Q4
$107K Buy
+170
New +$83.1K ﹤0.01% 3591

Other funds holding CDLX

Group One Trading's CDLX Position: Q1 2026 in Review

Group One Trading reduced its Cardlytics (CDLX) stake by 88% in Q1 2026, selling an estimated $41.4K and leaving 590 shares worth $6.19K. The position accounts for ﹤0.01% of the portfolio, ranked #6615.

Group One Trading first reported a position in CDLX in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.7M in Q1 2024. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.

  • Group One Trading held 590 shares of Cardlytics worth $6.19K as of Q1 2026.
  • Group One Trading sold 4,243 Cardlytics shares in Q1 2026, an estimated $41.4K.
  • Cardlytics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6615 holding.
  • Group One Trading first reported a position in Cardlytics in Q4 2019 and has held it in 19 quarters since.
  • Group One Trading's Cardlytics position peaked at $1.7M in Q1 2024.
  • 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.